Get the Stockscreener App
8.955
1.53%
0.135
Valneva Se Adr stock is traded at $8.955, with a volume of 10,570.
It is up +1.53% in the last 24 hours and up +2.11% over the past month.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
See More
Previous Close:
$8.82
Open:
$8.92
24h Volume:
10,570
Relative Volume:
0.30
Market Cap:
$773.53M
Revenue:
$213.45M
Net Income/Loss:
$-72.46M
P/E Ratio:
-9.0127
EPS:
-0.9936
Net Cash Flow:
$-47.28M
1W Performance:
+6.48%
1M Performance:
+2.11%
6M Performance:
+54.13%
1Y Performance:
+89.72%
1-Day Range:
$8.8501
$8.98
1-Week Range:
$8.07
$8.98
52-Week Range:
$4.20
$12.25
Valneva Se Adr Stock (VALN) Company Profile
Compare VALN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
8.955 | 761.87M | 213.45M | -72.46M | -47.28M | -0.9936 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Resumed | H.C. Wainwright | Buy |
| Aug-03-22 | Initiated | H.C. Wainwright | Buy |
Valneva Se Adr Stock (VALN) Latest News
Valneva (NASDAQ:VALN) Shares Up 4.9%What's Next? - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 4.6%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap UpTime to Buy? - MarketBeat
Valneva (NASDAQ:VALN) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Valneva SE Sponsored ADR $VALN - MarketBeat
Valneva stock rises after positive final Phase 2 results for chikungunya vaccine - Investing.com India
VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewswire Inc.
Valneva (NASDAQ:VALN) Stock Price Down 3.1%What's Next? - MarketBeat
Valneva stock rises after positive Lyme disease vaccine booster data - Investing.com
Valneva SE earnings beat by $0.02, revenue fell short of estimates - Investing.com
Valneva (VALN) Projected to Post Earnings on Thursday - MarketBeat
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - 2822news.com
Free cash flow per share of Valneva SE Sponsored ADR – LS:A3CPD1 - TradingView
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat
Valneva's (VALN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8% – Time to Sell? - Defense World
Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3) - Barchart.com
Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends
Valneva (NASDAQ:VALN) Shares Gap DownWhat's Next? - MarketBeat
Valneva stock falls after FDA suspension forces guidance cut - Investing.com
Valneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10% - Investing.com
VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Valneva (NASDAQ:VALN) Trading 5.6% HigherShould You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect - ACCESS Newswire
Valneva Se Adr Stock (VALN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):